• Bloland P, Lackritz E, Kazembe P, Were JBO, Steketee R & Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932937.
  • Brasseur P, Guigemdé R, Diallo S et al. (1999) Amodiaquine remains effective for treating malaria in West and Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 645650.
  • Guigemdé TR, Aoba A, Ouedraogo JB & Lamizana L (1994) Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982–1991). American Journal of Tropical Medicine and Hygiene 50, 699704.
  • Müller O, Becher H, Baltussen A et al. (2001) Effect of zinc supplementation on malaria morbidity among West African children: a randomized double-blind placebo-controlled trial. British Medical Journal 322, 15671572.
  • Nuwaha F (2001) The challenge of chloroquine resistant malaria in sub-Saharan Africa. Health Policy and Planning 16, 112.
  • Plowe CV, Doumbo OK, Djimde A et al. (2001) Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy. American Journal of Tropical Medicine and Hygiene 64, 242246.
  • Sudre P, Breman JG, McFarland D, Koplan JP (1992) Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. International Journal of Epidemiology, 21, 146154.
  • Trape J (2001) The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene 64 (Suppl.), 1217.
  • WHO (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. World Health Organization, Geneva, WHO/MAL/96.1077.